Cortical Dynamics Patent and Advisory Panel Appoint Update
Cortical Dynamics Patent and Advisory Panel Appoint Update
Perth, Jan 22, 2021 AEST (ABN Newswire) - BPH Energy Ltd (ASX:BPH) investee company Cortical Dynamics Ltd ("Cortical") is pleased to announce the issuance of European Patent Number 2088924 "Neurodiagnostic Monitoring and display System" in Belgium, France, Germany and United Kingdom.

Cortical has developed an extensive patent portfolio encapsulating the BARM, providing critical patent protection across a number of key brain monitoring markets.

Corticals' competitive advantage is underpinned by a strong patent position covered by six patent families and 26 granted patents.

Currently, Cortical has patents awarded in Australia, New Zealand, Japan, the People's Republic of China, Europe and the United States.

Advisory Panel Appointment

Cortical has also confirmed the appointment of Jamie Stanistreet to the Cortical Dynamics Advisory Committee.

From 2001-2018 Jamie was the Managing Director and Vice President of Medtronic Aust /NZ. Medtronic is currently ranked as the world's largest medical device company.

Under his tenure Medtronic revenue grew 10-fold, and he managed over 950 employees. Medtronic's focus on Medical devices includes Cardiology, Spine, Surgery, Brain Modulation, ENT, Pain, Stroke & Diabetes.

He was a member of the APAC Leadership Team. Jamie also served as Vice Chairman with the Medical Technology Association of Australia for several years.

Jamie has over 40 years' experience in the Medical Device industry and is an accountant by trade.

He was finalist in the CEO Magazine Executive of the year award 2014 - 2015 and won the Medical Technology Association of Australia inaugural Outstanding Achievement Award 2013.

Jamie's experience, connections and knowledge will be invaluable to the commercial development of Cortical Dynamics.

About BPH Energy Limited

BPH EnergyBPH Energy Limited (ASX:BPH) is an Australian Securities Exchange listed company developing biomedical research and technologies within Australian Universities and Hospital Institutes.

The company provides early stage funding, project management and commercialisation strategies for a direct collaboration, a spin out company or to secure a license.

BPH provides funding for commercial strategies for proof of concept, research and product development, whilst the institutional partner provides infrastructure and the core scientific expertise.

BPH currently partners with several academic institutions including The Harry Perkins Institute for Medical Research and  Swinburne University of Technology (SUT).



David Breeze
T: +61 8 9328 8366

Related Companies

BPH Energy Limited

ABN Newswire This Page Viewed:  (Last 7 Days: 48) (Last 30 Days: 429) (Since Published: 1760)